Cerulean Pharma Inc Stock Nasdaq
Equities
US15708Q1058
Biotechnology & Medical Research
Sales 2024 * | 2.62M 3.6M | Sales 2025 * | 27.84M 38.22M | Capitalization | 47.27M 64.89M |
---|---|---|---|---|---|
Net income 2024 * | -23M -31.57M | Net income 2025 * | -10M -13.73M | EV / Sales 2024 * | 18 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.7 x |
P/E ratio 2024 * |
-1.99
x | P/E ratio 2025 * |
-4.15
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.36% |
Latest transcript on Cerulean Pharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 14-12-31 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 14-12-31 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 19-11-19 |
Chairman | 75 | 13-12-31 |
1st Jan change | Capi. | |
---|---|---|
+48.67% | 58.71B | |
-2.76% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.25% | 26.55B | |
-23.10% | 18.98B | |
+1.88% | 12.51B | |
+26.43% | 12.08B | |
+21.74% | 11.94B |